Tissue Engineering & Biomaterials
Scaffolds, 3D bioprinting and regenerative medicine.
Tissue engineering is converging with high-resolution bioprinting, induced pluripotent stem cell biology, and decellularized scaffolds to produce functional tissue constructs at clinically relevant scales. Sessions will cover volumetric bioprinting and digital light processing approaches (Prellis, Readily3D) for vascularized constructs, organoid and assembloid systems modeling brain, liver, and intestine, and the BIO-X and Aspect Biosystems platforms moving toward bioprinted therapeutic tissues. The track will also feature self-assembling peptide hydrogels, GelMA and decellularized ECM bioinks, and translational progress in bioengineered skin (Vericel), cartilage, and pancreatic islet replacement (Vertex VX-880, ViaCyte).
- Volumetric and DLP bioprinting for vascularized constructs
- iPSC-derived organoids and assembloids for disease modeling
- Bioengineered islets: Vertex VX-880, encapsulation strategies
- Decellularized ECM scaffolds and recellularization
- GelMA, alginate, and self-assembling peptide bioinks
- Vascularization strategies: sacrificial templating, angiogenic factors
- Bioprinted skin and cartilage: clinical translation pathways